Etiket: BAT90
The radiotherapy process is at a turning point. No more long and exhausting cycles: the administration of the treatment in the future will take place in the opetoria room in a single session. The clinical data of the new BAT-90 radiotherapy are promising and open important prospects for nuclear medicine in oncology, for improving the quality of life and patient outcomes.
L‘agency BetaGlue Technologies announces the treatment of first patient with BAT-90the new anticancer radiotherapy developed by the Company. The first patient with liver cancer recruited from the trial was subjected…